Ingevity Gelecekteki Büyüme

NYSE:NGVT - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
12/31/2026	1,540	172	163	278	3
12/31/2025	1,451	144	137	247	4
12/31/2024	1,414	-442	1	112	4
9/30/2024	1,479	-564	28	110	N/A
6/30/2024	1,548	-431	72	169	N/A
3/31/2024	1,640	-112	87	188	N/A
12/31/2023	1,692	-5	95	205	N/A
9/30/2023	1,704	127	128	257	N/A
6/30/2023	1,740	177	120	252	N/A
3/31/2023	1,678	202	154	294	N/A
12/31/2022	1,668	212	171	313	N/A
9/30/2022	1,621	225	160	291	N/A
6/30/2022	1,516	146	171	291	N/A
3/31/2022	1,454	130	152	266	N/A
12/31/2021	1,392	118	190	293	N/A
9/30/2021	1,381	135	273	370	N/A
6/30/2021	1,336	209	272	360	N/A
3/31/2021	1,248	185	264	343	N/A
12/31/2020	1,216	181	270	352	N/A
9/30/2020	1,194	180	199	285	N/A
6/30/2020	1,222	170	222	313	N/A
3/31/2020	1,304	206	238	344	N/A
12/31/2019	1,293	184	161	276	N/A
9/30/2019	1,268	182	159	276	N/A
6/30/2019	1,219	171	131	252	N/A
3/31/2019	1,175	161	126	234	N/A
12/31/2018	1,134	169	158	252	N/A
9/30/2018	1,085	169	134	207	N/A
6/30/2018	1,037	153	N/A	193	N/A
3/31/2018	989	138	N/A	178	N/A
12/31/2017	972	127	N/A	174	N/A
9/30/2017	954	94	N/A	187	N/A
6/30/2017	942	53	N/A	144	N/A
3/31/2017	927	45	N/A	131	N/A
12/31/2016	908	35	N/A	128	N/A
9/30/2016	898	34	N/A	111	N/A
6/30/2016	902	64	N/A	100	N/A
3/31/2016	919	66	N/A	92	N/A
12/31/2015	958	80	N/A	72	N/A
9/30/2015	999	99	N/A	76	N/A
6/30/2015	1,025	115	N/A	111	N/A
3/31/2015	1,022	121	N/A	106	N/A
12/31/2014	1,036	129	N/A	139	N/A
12/31/2013	980	119	N/A	137	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: NGVT önümüzdeki 3 yıl içerisinde kârlı hale gelmesi öngörülüyor; bu da tasarruf oranından ( 2.5% ) daha hızlı bir büyüme olarak değerlendiriliyor.

Kazançlar ve Piyasa: NGVT önümüzdeki 3 yıl içerisinde karlı hale gelmesi öngörülüyor ki bu da ortalama piyasa büyümesinin üzerinde kabul ediliyor.

Yüksek Büyüme Kazançları: NGVT önümüzdeki 3 yıl içinde karlı hale gelmesi bekleniyor.

Gelir ve Pazar: NGVT şirketinin gelirinin (yıllık 2.3% ) US pazarından (yıllık 8.8% ) daha yavaş büyümesi öngörülüyor.

Yüksek Büyüme Geliri: NGVT şirketinin gelirinin (yıllık 2.3% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: NGVT 'un Özsermaye Getirisi'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Ingevity Gelecekteki Büyüme

Future kriter kontrolleri 3/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Ingevity Corporation Reaffirms Financial Guidance for the Full Year 2024

Price target decreased by 7.5% to US$49.60

Ingevity Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Price target decreased by 9.7% to US$52.00

Ingevity Corporation Revises Earnings Guidance for the Full Year 2024

Price target increased by 7.4% to US$62.14

Recent updates

Third quarter 2024 earnings: EPS misses analyst expectations

Ingevity Corporation Reaffirms Financial Guidance for the Full Year 2024

Is Ingevity (NYSE:NGVT) A Risky Investment?

Ingevity Announces Chief Executive Officer Changes

Ingevity Corporation's (NYSE:NGVT) Prospects Need A Boost To Lift Shares

Ingevity: The Risk-Reward Ratio Is Still Unfavorable

Price target decreased by 7.5% to US$49.60

Ingevity Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Price target decreased by 9.7% to US$52.00

Ingevity Corporation Revises Earnings Guidance for the Full Year 2024

Ingevity Corporation to Report Q2, 2024 Results on Jul 31, 2024

Ingevity (NYSE:NGVT) Use Of Debt Could Be Considered Risky

Ingevity Corporation(NYSE:NGVT) dropped from Russell 2000 Growth-Defensive Index

Ingevity Corporation Announces Executive Changes

Should You Investigate Ingevity Corporation (NYSE:NGVT) At US$45.90?

Price target increased by 7.4% to US$62.14

Ingevity Corporation Reiterates Earnings Guidance for the Full Year 2024

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Ingevity Corporation to Report Q1, 2024 Results on May 01, 2024

Are Investors Undervaluing Ingevity Corporation (NYSE:NGVT) By 44%?

Is Ingevity (NYSE:NGVT) A Risky Investment?

Ingevity Corporation Announces Resignation of William J. Slocum from Board

Ingevity Corporation, Annual General Meeting, Apr 23, 2024

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Ingevity Corporation Provides Earnings Guidance for the Year 2024

Ingevity Corporation to Report Q4, 2023 Results on Feb 21, 2024

What Is Ingevity Corporation's (NYSE:NGVT) Share Price Doing?

Ingevity Corporation (NYSE:NGVT) Doing What It Can To Lift Shares

These Analysts Just Made An Incredible Downgrade To Their Ingevity Corporation (NYSE:NGVT) EPS Forecasts

Price target decreased by 8.9% to US$53.29

Consensus EPS estimates fall by 13%

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Price target decreased by 11% to US$58.50

Ingevity Corporation to Report Q3, 2023 Results on Nov 01, 2023

Is It Time To Consider Buying Ingevity Corporation (NYSE:NGVT)?

Ingevity Corporation: The Risk To Reward Is Currently Favorable

Ingevity (NYSE:NGVT) Takes On Some Risk With Its Use Of Debt

Is There An Opportunity With Ingevity Corporation's (NYSE:NGVT) 31% Undervaluation?

Consensus EPS estimates fall by 29%

Now 20% undervalued after recent price drop

Price target decreased by 8.9% to US$69.14

New major risk - Financial position

Second quarter 2023 earnings: EPS misses analyst expectations

Ingevity Corporation to Report Q2, 2023 Results on Aug 02, 2023

Ingevity Corporation: Headwinds Are Temporary

Ingevity (NYSE:NGVT) Takes On Some Risk With Its Use Of Debt

Investor sentiment improves as stock rises 16%

Is There Now An Opportunity In Ingevity Corporation (NYSE:NGVT)?

Consensus EPS estimates fall by 13%

Investor sentiment deteriorates as stock falls 20%

Price target decreased by 8.5% to US$88.71

Ingevity Corporation Announces Sales Guidance for 2023

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Insider recently sold US$117k worth of stock

Consensus EPS estimates fall by 11%, revenue upgraded

Full year 2022 earnings: EPS misses analyst expectations

Ingevity Corporation to Report Q4, 2022 Results on Feb 27, 2023

We Think Ingevity (NYSE:NGVT) Can Stay On Top Of Its Debt

Is Ingevity Corporation (NYSE:NGVT) Potentially Undervalued?

Insider recently sold US$67k worth of stock

Insider exercised options and sold US$54k worth of stock

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Ingevity Corporation Provides Earnings Guidance for the Year 2022

Ingevity Corporation to Report Q3, 2022 Results on Nov 02, 2022

Ingevity Corporation (NYSE:NGVT) acquired Ozark Logistics, LLC and Ozark Materials, LLC from Ozark Holdings, Inc. for approximately $330 million.

Ingevity Corporation (NYSE:NGVT) Shares Could Be 39% Below Their Intrinsic Value Estimate

Is It Time To Consider Buying Ingevity Corporation (NYSE:NGVT)?

Ingevity Corporation (NYSE:NGVT) reached an agreement to acquire Ozark Logistics, LLC and Ozark Materials, LLC from Ozark Holdings, Inc. for approximately $330 million.

Second quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat